Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM

BACKGROUND: The role of inherent tumor heterogeneity and an immunosuppressive microenvironment in therapeutic resistance has been determined to be of importance for the better management of glioblastoma multiforme (GBM). Some studies have suggested that combined drugs with divergent mechanisms may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ching-Ann, Harn, Horng-Jyh, Chen, Kuan-Pin, Lee, Jui-Hao, Lin, Shinn-Zong, Chiu, Tsung-Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132698/
https://www.ncbi.nlm.nih.gov/pubmed/35646111
http://dx.doi.org/10.1155/2022/3236058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132698/
https://www.ncbi.nlm.nih.gov/pubmed/35646111
http://dx.doi.org/10.1155/2022/3236058

Ejemplares similares